- Home
- TSBK vs EDIT Comparison
TSBK vs EDIT Comparison
Compare TSBK & EDIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | TSBK | EDIT |
|---|---|---|
| Founded | 1915 | 2013 |
| Country | United States | United States |
| Employees | 280 | N/A |
| Industry | Banks | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 310.0M | 310.9M |
| IPO Year | 1997 | 2016 |
Fundamental Metrics
Financial Performance| Metric | TSBK | EDIT |
|---|---|---|
| Price | $39.25 | $2.63 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $5.30 |
| AVG Volume (30 Days) | 18.6K | ★ 1.2M |
| Earning Date | 04-28-2026 | 05-11-2026 |
| Dividend Yield | ★ 2.87% | N/A |
| EPS Growth | 21.93 | ★ 37.50 |
| EPS | ★ 1.94 | N/A |
| Revenue | N/A | ★ $31,937,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $20.46 | ★ N/A |
| Revenue Growth | N/A | ★ 132.64 |
| 52 Week Low | $29.30 | $1.43 |
| 52 Week High | $43.55 | $4.54 |
Technical Indicators
Market Signals| Indicator | TSBK | EDIT |
|---|---|---|
| Relative Strength Index (RSI) | 41.08 | 38.80 |
| Support Level | $37.31 | $2.42 |
| Resistance Level | $39.98 | $2.76 |
| Average True Range (ATR) | 1.47 | 0.21 |
| MACD | -0.22 | -0.06 |
| Stochastic Oscillator | 42.63 | 5.67 |
Price Performance
Historical ComparisonAbout TSBK Timberland Bancorp Inc.
Timberland Bancorp Inc is a bank holding company for Timberland Bank. The bank offers banking services including personal checking and savings accounts, debit cards, health savings accounts, online and mobile banking, online bill pay, 24-hour phone banking, and Zelle. Business services include business checking accounts, online banking, remote deposit, ACH transactions, Autobooks, and insured cash sweep services. The bank also provides lending services such as personal credit cards, home loans, home equity borrowing, construction loans, and SBA loans. In addition, it offers loans to real estate, including residential and commercial real estate, multi-family construction loans, one- to four-family residential loans, multi-family loans, commercial real estate loans, and land loans.
About EDIT Editas Medicine Inc.
Editas Medicine Inc is a clinical-stage genome editing company dedicated to developing potentially transformative genomic medicines to treat a broad range of serious diseases. The company focuses on developing a proprietary gene editing platform based on CRISPR technology and continues to expand its capabilities. CRISPR uses a protein-RNA complex composed of an enzyme, including either Cas9 (CRISPR-associated protein 9) or Cas12a (CRISPR from Prevotella and Francisella 1, also known as Cpf1). The company has a single operating segment, which is the business of developing and commercializing gene editing technology.